Evidence map›Paper›PMID 40990820›Full record

ArticleProteins2026

Iterative Modeling via Structural Diffusion (IMSD): Exploring Fold-Switching Pathways in Metamorphic Proteins Using AlphaFold2-Based Generative Diffusion Model UFConf.

Dmitrii A Luzik, Nikolai R Skrynnikov

Abstract read
In one paragraph

Article in Proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dmitrii A LuzikLaboratory of Biomolecular NMR, St. Petersburg State University, St. Petersburg, Russia.
Nikolai R SkrynnikovLaboratory of Biomolecular NMR, St. Petersburg State University, St. Petersburg, Russia.ORCID https://orcid.org/0000-0002-7097-9192

Funding

St. Petersburg State University 127400313
6 · The paper itself

Abstract

Metamorphic proteins (MPs) can fold into two or more distinct spatial structures. Increasing interest in MPs has spurred the search for computational tools to predict proteins fold-switching potential and model their refolding pathways. Here we address this problem by using the recently reported generative diffusion predictor UFConf, based on the AlphaFold2 network. We have developed a new UFConf-driven algorithm dubbed IMSD (iterative modeling via structural diffusion) to model the MP's path from one conformational state to another. In brief, we begin with the experimental structure of state A, perturb it through the "noising" process, and infer a number of models (replicas) through the reverse diffusion or "denoising" process. From this set of models, we choose the one that is closest to the alternative structure B; then we use it as a starting point to perform another round of noising/denoising and thus generate the next batch of replicas. Repeating this process in an iterative fashion, we have been able to map the entire path from state A to state B for metamorphic proteins GA98, SA1 V90T, and the C-terminal domain of RfaH. The obtained representation of the fold-switching pathways in these MPs is consistent with the dual-funnel energy landscape observed in the previous modeling studies and shows good agreement with the available experimental data. The new UFConf-based IMSD protocol can be viewed as a part of the emerging generation of modeling tools aiming to model protein dynamics by means of deep learning technology.

Indexed as

Computational BiologyProtein FoldingProteinsAlgorithmsDatabases, ProteinDiffusionModels, MolecularProtein ConformationSoftwareProteinsfolding/unfolding intermediatesgenerative diffusion modelmetamorphic proteinsmodeling of fold‐switching pathwaysparallel cascade selection molecular dynamics

Identifiers

PMID40990820
PMCPMC12779232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.